In February of 2021, the One Voice Against Cancer (OVAC) coalition sent a letter to House and Senate offices regarding the cancer communities priorities’ for funding in FY 2022 for the NIH, NCI and CDC’s cancer programs. The letter also outlines the need for emergency funding for the NIH to address COVID-19’s impact on the research enterprise and clinical trials.

COVID and FY 2022 OVAC letter FINAL 2.17.2021